Treatment of Cold Sores in Children
For mild cold sores (herpes labialis) in children, treat with oral acyclovir 20 mg/kg per dose (maximum 400 mg/dose) three times daily for 5-10 days, starting as early as possible in the prodromal stage or within 48 hours of lesion onset. 1
Treatment Algorithm by Severity
Mild Symptomatic Cold Sores (Most Common)
- Oral acyclovir: 20 mg/kg per dose (max 400 mg/dose) three times daily for 5-10 days 1
- Start treatment immediately at first sign of symptoms (tingling, burning) or within 48 hours of visible lesions 2
- This is the standard first-line therapy with strong evidence (AI recommendation)
Moderate to Severe Gingivostomatitis
If the child has extensive oral involvement with fever, difficulty eating, or severe pain:
- Start with IV acyclovir: 5-10 mg/kg per dose three times daily 1
- Transition to oral acyclovir once lesions begin to regress (AI recommendation)
- Continue therapy until lesions completely heal
Severe/Disseminated Disease or CNS Involvement
For children outside the neonatal period with suspected encephalitis or disseminated disease:
- IV acyclovir: 10 mg/kg three times daily for 21 days 1
- This requires hospitalization and specialist consultation
Important Clinical Considerations
Timing is Critical: The effectiveness of antiviral therapy depends heavily on early initiation. Treatment started during the prodromal phase (before visible lesions) or within the first 48 hours provides optimal benefit in reducing lesion duration and pain 2, 3.
Alternative Agents: While valacyclovir and famciclovir are approved for adults and adolescents, no pediatric preparation exists and dosing data in young children are limited 1. These should only be used in older children/adolescents who can receive adult dosing (valacyclovir 1g twice daily, famciclovir 500mg twice daily).
Topical Therapy: Topical acyclovir cream (5%) or penciclovir can be used but are significantly less effective than oral therapy 2, 3. They primarily provide modest symptom relief and do not prevent recurrences. Reserve topical agents for situations where oral therapy is refused or contraindicated.
Recurrent Episodes
For children with frequent severe recurrences (≥6 episodes per year):
- Consider chronic suppressive therapy with oral acyclovir 4, 2
- Dosing: 20 mg/kg twice daily (AI recommendation for recurrent HSV)
- This approach reduces recurrence frequency but requires ongoing monitoring
Monitoring for Neutropenia: Children on long-term acyclovir suppression require periodic complete blood counts, as neutropenia occurs in approximately 46% of children on chronic therapy, though usually self-limited 5.
Common Pitfalls to Avoid
- Delayed treatment: Waiting for full lesion development before starting therapy significantly reduces efficacy
- Inadequate dosing: Using adult fixed doses instead of weight-based dosing in children <45 kg
- Premature discontinuation: Stopping therapy when lesions improve rather than completing the full course
- Confusing with bacterial infection: Cold sores may become secondarily infected, but primary treatment remains antiviral
Acyclovir-Resistant Cases
If lesions fail to respond after 7-10 days of appropriate acyclovir therapy:
- Foscarnet: 40 mg/kg per dose IV three times daily or 60 mg/kg twice daily 1
- This requires specialist consultation and hospitalization
- Resistance is rare in immunocompetent children but more common in HIV-infected or immunocompromised patients
The evidence strongly supports oral acyclovir as first-line therapy for pediatric cold sores, with IV therapy reserved for severe presentations. The key to successful treatment is early initiation and appropriate weight-based dosing.